JP2017533197A5 - - Google Patents

Download PDF

Info

Publication number
JP2017533197A5
JP2017533197A5 JP2017521096A JP2017521096A JP2017533197A5 JP 2017533197 A5 JP2017533197 A5 JP 2017533197A5 JP 2017521096 A JP2017521096 A JP 2017521096A JP 2017521096 A JP2017521096 A JP 2017521096A JP 2017533197 A5 JP2017533197 A5 JP 2017533197A5
Authority
JP
Japan
Prior art keywords
composition
strain
stopband
composition according
culture collection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017521096A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017533197A (ja
JP6765370B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/074375 external-priority patent/WO2016062771A1/en
Publication of JP2017533197A publication Critical patent/JP2017533197A/ja
Publication of JP2017533197A5 publication Critical patent/JP2017533197A5/ja
Application granted granted Critical
Publication of JP6765370B2 publication Critical patent/JP6765370B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017521096A 2014-10-21 2015-10-21 プロバイオティクス組成物及びプレバイオティクス組成物 Active JP6765370B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14382412.6 2014-10-21
EP14382412 2014-10-21
PCT/EP2015/074375 WO2016062771A1 (en) 2014-10-21 2015-10-21 Probiotic and prebiotic compositions

Publications (3)

Publication Number Publication Date
JP2017533197A JP2017533197A (ja) 2017-11-09
JP2017533197A5 true JP2017533197A5 (enExample) 2018-12-06
JP6765370B2 JP6765370B2 (ja) 2020-10-07

Family

ID=51846603

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017521096A Active JP6765370B2 (ja) 2014-10-21 2015-10-21 プロバイオティクス組成物及びプレバイオティクス組成物

Country Status (14)

Country Link
US (1) US10179153B2 (enExample)
EP (1) EP3209307B1 (enExample)
JP (1) JP6765370B2 (enExample)
KR (1) KR102517581B1 (enExample)
CN (1) CN107073049B (enExample)
AU (1) AU2015334989B2 (enExample)
BR (1) BR112017008184B1 (enExample)
CA (1) CA2965214C (enExample)
DK (1) DK3209307T3 (enExample)
ES (1) ES2936842T3 (enExample)
PH (1) PH12017500708A1 (enExample)
PL (1) PL3209307T3 (enExample)
RU (1) RU2741836C2 (enExample)
WO (1) WO2016062771A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015227075A1 (en) * 2014-03-06 2016-09-22 Ohio State Innovation Foundation Probiotic formulations and methods for use
US10624934B2 (en) 2014-03-06 2020-04-21 Research Institute At Nationwide Children's Hospital Prebiotic formulations
US11959125B2 (en) 2016-09-15 2024-04-16 Sun Genomics, Inc. Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample
KR101851297B1 (ko) * 2017-02-13 2018-04-23 강원대학교 산학협력단 신규한 락토바실러스 루테리 균주 및 그 항균 용도
US20200113950A1 (en) * 2017-06-30 2020-04-16 The Rockefeller University Human microbiota derived N-acyl amides for the treatment of human disease
KR20190070457A (ko) 2017-12-13 2019-06-21 주식회사 오투파워 이산화염소를 포함하는 닭 대장균증 예방을 위한 음용수 첨가용 조성물
US12569524B2 (en) 2018-10-22 2026-03-10 Research Institute At Nationwide Children's Hospital Compositions and methods for preventing and treating antibiotic induced pathologies using probiotics in the biofilm state
CN109385387B (zh) * 2018-12-28 2022-04-05 上海源耀农牧科技有限公司 一种抗tgev的罗伊氏乳杆菌及其应用
KR20220016481A (ko) 2019-06-03 2022-02-09 더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 패혈증 및 괴사성 장염 유도된 신경발달 결핍의 예방을 위한 프리바이오틱 제형
CN112877231B (zh) * 2019-11-29 2023-06-23 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 具有抑菌和抗氧化活性的乳酸菌及其应用
US20230158088A1 (en) * 2020-03-26 2023-05-25 Persephone Biosciences, Inc. Compositions for modulating gut microflora populations, enhancing drug potency and treating viral infections, and methods for making and using same
US20230340625A1 (en) * 2020-04-13 2023-10-26 Sun Genomics, Inc. Method and system for detecting and treating exposure to an infectious pathogen
WO2021252760A2 (en) * 2020-06-10 2021-12-16 The Board Of Trustees Of The University Of Arkansas Swine origin probiotics that promote health and growth performance in pigs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
CA2517245C (en) * 2003-02-28 2009-01-20 Mcgill University Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
AU2003247193A1 (en) 2003-07-23 2005-02-04 M.D.Lab Corp. Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
KR100513168B1 (ko) * 2003-08-27 2005-09-07 주식회사 프로바이오닉 돼지 유행성 설사증 (PED) 코로나바이러스 및 유해 미생물 억제 활성을 가지는 신규 내 산성 엔테로코커스 훼카리스Probio-056 및 이를 함유하는 생균활성제
EP1997499A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
CA2783414A1 (en) * 2012-07-22 2014-01-22 Integral Medical Inc. Probiotic composition
ES2940463T3 (es) 2012-09-25 2023-05-08 Aquilon Cyl S L Composiciones probióticas y prebióticas

Similar Documents

Publication Publication Date Title
RU2017113027A (ru) Пробиотические и пребиотические соединения
RU2372788C2 (ru) Пробиотическая стимулирующая здоровье или производительность кормовая добавка или добавка к питьевой воде, а также ее применение
Resende et al. Prevalence and persistence of potentially pathogenic and antibiotic resistant bacteria during anaerobic digestion treatment of cattle manure
Soleimani et al. Antagonistic activity of probiotic lactobacilli against Staphylococcus aureus isolated from bovine mastitis
Sabia et al. Detection and partial characterization of a bacteriocin-like substance produced by Lactobacillus fermentum CS57 isolated from human vaginal secretions
PH12015502416A1 (en) Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
RU2018113245A (ru) Новая лактобактерия, характеризующаяся различными функциями, и ее применение
JP2016522810A5 (enExample)
Chen et al. Impact of enrofloxacin and florfenicol therapy on the spread of OqxAB gene and intestinal microbiota in chickens
JP2017519730A5 (enExample)
Kim et al. Survival, prophage induction, and invasive properties of lysogenic Salmonella Typhimurium exposed to simulated gastrointestinal conditions
Aazami et al. Characterization of some potentially probiotic Lactobacillus strains isolated from Iranian native chickens
CN113040390B (zh) 一株益生、耐盐约氏乳杆菌及其在畜禽水产养殖中防治病原菌的应用
Nawaz et al. Screening and characterization of new potentially probiotic lactobacilli from breast-fed healthy babies in Pakistan
JP2014113137A5 (enExample)
CN113604387B (zh) 一株耐盐、耐高温罗伊氏乳杆菌及其在畜禽水产养殖中防治病原菌的应用
MX2009006808A (es) Eliminacion e inhibicion del crecimiento del estafilococo aureus resistente a la meticilina mediante bacterias del acido lactico.
Park et al. Antimicrobial effect of lactic acid producing bacteria culture condensate mixture (LCCM) against Salmonella enteritidis
JP2008173050A5 (enExample)
EP3168292B1 (en) New lactobacillus plantarum strain amt14 and composition containing the strain of lactobacillus plantarum amt14
KR20210067274A (ko) 붉바리 양식용 미생물 제제
Kugadas et al. Growth of Mannheimia haemolytica: inhibitory agents and putative mechanism of inhibition
US20180303884A1 (en) Strain of bacteria and composition comprising the same
NZ730699B2 (en) Probiotic and prebiotic compositions
Al-Mathkhury et al. Probiotic effect of lactobacilli on mice incisional wound infections